XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2021   61,660,996      
Beginning balance at Dec. 31, 2021 $ 988.2 $ 0.0 $ 1,553.5 $ (561.9) $ (3.4)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units (in shares)   97,743      
Exercise of stock options and distribution of restricted stock units 0.6   0.6    
Stock-based compensation 14.1   14.1    
Net loss (74.8)     (74.8)  
Other comprehensive income (loss) (15.4)       (15.4)
Ending balance (in shares) at Mar. 31, 2022   61,758,739      
Ending balance at Mar. 31, 2022 912.7 $ 0.0 1,568.2 (636.7) (18.8)
Beginning balance (in shares) at Dec. 31, 2021   61,660,996      
Beginning balance at Dec. 31, 2021 988.2 $ 0.0 1,553.5 (561.9) (3.4)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Issuance of common stock from acquisition of Metromile (Note 5) (in shares)   6,901,934      
Issuance of common stock from acquisition of Metromile (Note 5) 137.7   137.7    
Net loss (234.1)        
Ending balance (in shares) at Sep. 30, 2022   69,120,346      
Ending balance at Sep. 30, 2022 906.8 $ 0.0 1,738.1 (796.0) (35.3)
Beginning balance (in shares) at Mar. 31, 2022   61,758,739      
Beginning balance at Mar. 31, 2022 912.7 $ 0.0 1,568.2 (636.7) (18.8)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units (in shares)   108,838      
Exercise of stock options and distribution of restricted stock units 0.4   0.4    
Stock-based compensation 13.9   13.9    
Net loss (67.9)     (67.9)  
Other comprehensive income (loss) (10.0)       (10.0)
Ending balance (in shares) at Jun. 30, 2022   61,867,577      
Ending balance at Jun. 30, 2022 849.1 $ 0.0 1,582.5 (704.6) (28.8)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units (in shares)   350,835      
Exercise of stock options and distribution of restricted stock units 2.3   2.3    
Stock-based compensation 15.6   15.6    
Net loss (91.4)     (91.4)  
Other comprehensive income (loss) (6.5)       (6.5)
Ending balance (in shares) at Sep. 30, 2022   69,120,346      
Ending balance at Sep. 30, 2022 $ 906.8 $ 0.0 1,738.1 (796.0) (35.3)
Beginning balance (in shares) at Dec. 31, 2022 69,275,030 69,275,030      
Beginning balance at Dec. 31, 2022 $ 866.8 $ 0.0 1,754.1 (859.7) (27.6)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units (in shares)   174,318      
Exercise of stock options and distribution of restricted stock units 0.1   0.1    
Stock-based compensation 15.4   15.4    
Net loss (65.8)     (65.8)  
Other comprehensive income (loss) 5.3       5.3
Ending balance (in shares) at Mar. 31, 2023   69,449,348      
Ending balance at Mar. 31, 2023 $ 821.8 $ 0.0 1,769.6 (925.5) (22.3)
Beginning balance (in shares) at Dec. 31, 2022 69,275,030 69,275,030      
Beginning balance at Dec. 31, 2022 $ 866.8 $ 0.0 1,754.1 (859.7) (27.6)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Net loss $ (194.5)        
Ending balance (in shares) at Sep. 30, 2023 69,909,356 69,909,356      
Ending balance at Sep. 30, 2023 $ 726.9 $ 0.0 1,800.2 (1,054.2) (19.1)
Beginning balance (in shares) at Mar. 31, 2023   69,449,348      
Beginning balance at Mar. 31, 2023 821.8 $ 0.0 1,769.6 (925.5) (22.3)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units (in shares)   218,828      
Exercise of stock options and distribution of restricted stock units 0.3   0.3    
Stock-based compensation 14.8   14.8    
Net loss (67.2)     (67.2)  
Other comprehensive income (loss) 1.3       1.3
Ending balance (in shares) at Jun. 30, 2023   69,668,176      
Ending balance at Jun. 30, 2023 771.0 $ 0.0 1,784.7 (992.7) (21.0)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units (in shares)   241,180      
Exercise of stock options and distribution of restricted stock units 0.1   0.1    
Stock-based compensation 15.4   15.4    
Net loss (61.5)     (61.5)  
Other comprehensive income (loss) $ 1.9       1.9
Ending balance (in shares) at Sep. 30, 2023 69,909,356 69,909,356      
Ending balance at Sep. 30, 2023 $ 726.9 $ 0.0 $ 1,800.2 $ (1,054.2) $ (19.1)